The Potency of Java Apple (Syzygium samarangense) AS α-Glucosidase and α-Amylase Inhibitor: An In-Silico Approach
http://www.doi.org/10.26538/tjnpr/v7i8.26
Keywords:
in silico, α-amylase, α-glucosidase, Syzygium samarangenseAbstract
Diabetes remains one of the health issues in Indonesia. The number of diabetes patients is increasing each year. The number of diabetes patients also impacts the use of diabetes medications, increasing the demand for diabetes drugs. Acarbose is commonly used to manage diabetes by inhibiting the α-glucosidase and α-amylase. However, acarbose has side effects such as diarrhea, abdominal bloating, and borborygmus. Therefore, an alternative with a similar mechanism to acarbose is needed. As reported that Java apple (Syzygium samarangense) has the potency to inhibit α-glucosidase and α-amylase. This study aimed to analyze the potency of the
ethyl acetate extract of Java apple stem bark as an α-glucosidase and α-amylase inhibitor using an in silico approach. The types of α-glucosidase used are human maltase-glucoamylase (MGAM) and human pancreatic α-amylase (HPA) as α-amylase. From 61 compounds presented in S. samarangense ethyl acetate extract, 17 compounds showed good inhibition and docked at the
same active site as acarbose (control drug), indicating that the compounds serve as α-glucosidase and α-amylase inhibitors. The binding affinity of these compounds ranges from -8.4 to -10.8kcal/mol. Three compounds (epigallocatechin, isoengeletin, and kaempferol-3-O-rhamnoside) showed good drug-likeness and drug score value. The drug-likeness value is 0.31525, 1.8995, and
1.9289; the drug score value is 0.82, 0.79, and 0.77, respectively. The toxicity of these compounds was not detected. Therefore, epigallocatechin, isoengeletin, and kaempferol-3-O-rhamnoside are promising drug candidates.
References
Pangribowo S. Infodatin: Tetap Produktif, Cegah, dan Atasi Diabetes Melitus. Jakarta: Kementerian Kesehatan Republik Indonesia; 2020.
Ministry of Health Republic of Indonesia. Laporan Nasional Riskesdas 2018. Jakarta; 2018.
Shinde J, Taldone T, Barletta M, Kunaparaju N, Hu B, Kumar S, Placido J, Zito SW. α-glucosidase inhibitory activity of Syzygium cumini (Linn.) Skeels seed kernel in vitro and in Goto-Kakizaki (GK) rats. Carbohydr Res. 2008;343(7):1278–81.
Wang X, Li J, Shang J, Bai J, Wu K, Liu J, Yang Z, Ou H, Shao L. Metabolites extracted from microorganisms as potential inhibitors of glycosidases (α-glucosidase and α-amylase): A review. Front Microbiol. 2022;13(November):1–13.
Bedekar A, Shah K, Koffas M. Natural Products for Type II Diabetes Treatment. 1st ed. Vol. 71, Advances in Applied Microbiology. Elsevier Inc.; 2010. 21–73 p.
Sudha P, Zinjarde SS, Bhargava SY, Kumar AR. Potent α-amylase inhibitory activity of Indian Ayurvedic medicinal plants. BMC Complement Altern Med. 2011;11.
Idris NS, Khandaker MM, Rashid ZM, Majrashi A, Alenazi MM, Nor ZM, Mohd Adnan AF, Mat N. Polyphenolic compounds and biological activities of leaves and fruits of Syzygium samarangense cv. ‘giant green’ at three different maturities. Horticulturae. 2023;9(3):1–23.
Mukaromah AS. Wax Apple (Syzygium samarangense(Blume) Merr. & L.M. Perry): A comprehensive review in phytochemical and physiological perspectives. Al-Hayat J Biol Appl Biol. 2020;3(1):40.
Shahreen S, Banik J, Hafiz A, Rahman S, Zaman AT, Shoyeb A, Chowdhury MH, Rahmatullah M. Antihyperglycemic activities of leaves of three edible fruit plants (Averrhoa carambola, Ficus hispida, and Syzygium samarangense) of Bangladesh. African J Tradit Complement Altern Med.
;9(2):287–91.
Zulcafli AS, Lim C, Ling AP, Chye S, Koh R. Antidiabetic potential of Syzygium sp.: An overview. Yale J Biol Med. 2020;93(2):307–25.
Khamchan A, Paseephol T, Hanchang W. Protective effect of wax apple (Syzygium samarangense (Blume) Merr. & L.M. Perry) against streptozotocin-induced pancreatic ß-cell damage in diabetic rats. Biomed Pharmacother. 2018;108(April):634–45.
Poongunran J, Perera HKI, Jayasinghe L, Fernando IT, Sivakanesan R, Araya H, Fujimoto Y. Bioassay-guided fractionation and identification of α-amylase inhibitors from Syzygium cumini leaves. Pharm Biol. 2017;55(1):206–11.
Nor I, Wirasutisna KR, Hartati R, Insanu M. The α-glucosidase inhibitory activity of avicularin and 4-O-methyl gallic acid isolated from Syzygium myrtifolium leaves. Saudi Pharm J. 2023;31(8):101677.
Pratama MRF, Poerwono H, Siswodiharjo S. ADMET properties of novel 5-O-benzoylpinostrobin derivatives. J Basic Clin Physiol Pharmacol. 2020;30(6):1–13.
Bhagat RT, Butle SR, Khobragade DS, Wankhede SB, Prasad CC, Mahure DS, Armarkar A V. Molecular docking in drug discovery. J Pharm Res Int. 2021;(September):46–58.
Syabana MA, Yuliana ND, Batubara I, Fardiaz D. α-glucosidase inhibitors from Syzygium polyanthum (Wight) Walp leaves as revealed by metabolomics and in silico approaches. J Ethnopharmacol. 2022;282(August 2021):114618.
Rashied RMH, Abdelfattah MAO, El-Beshbishy HA, ElShazly AM, Mahmoud MF, Sobeh M. Syzygium samarangense leaf extract exhibits distinct antidiabetic activities: Evidences from in silico and in vivo studies: Syzygium samarangense leaf extract exhibits distinct antidiabetic activities. Arab J Chem. 2022;15(6):103822.
Biswas B, Golder M, Devnath HS, Mazumder K, Sadhu SK. Comparative antihyperglycemic, analgesic and antiinflammatory potential of ethanolic aerial root extracts of Ceriops decandra and Ceriops tagal: Supported by molecular docking and ADMET analysis. Heliyon. 2023;9(3):e14254.
Demir C, Istifli ES. Docking-based virtual screening, ADMET, and network pharmacology prediction of anthocyanidins against human alpha-amylase and alphaglucosidase enzymes as potential antidiabetic agents. Int J Plant Based Pharm. 2022;2(2):271–83.
Saputri KE, Fakhmi N, Kusumaningtyas E, Priyatama D, Santoso B. Docking molekular potensi anti diabetes melitus tipe 2 turunan zerumbon sebagai inhibitor aldosa reduktase dengan autodock-vina. Chim Nat Acta. 2016;4(1):16.
Stevens N, Allred K. Antidiabetic potential of volatile cinnamon oil: A review and exploration of mechanisms using in silico molecular docking simulations. Molecules. 2022;27(3):853.
Akshatha JV, SantoshKumar HS, Prakash HS, Nalini MS. In silico docking studies of α-amylase inhibitors from the antidiabetic plant Leucas ciliata Benth. and an endophyte, Streptomyces longisporoflavus. 3 Biotech. 2021;11(2):1–16.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46(1–3):3–26.
Nunes DOS, Vinturelle R, Martins FJ, dos Santos TF, Valverde AL, Ribeiro CMR, Castro HC, Folly E. Biotechnological potential of eugenol and thymol derivatives against Staphylococcus aureus from bovine mastitis. Curr Microbiol. 2021;78(5):1846–55.
Rashid M. Design, synthesis and ADMET prediction of bisbenzimidazole as anticancer agent. Bioorg Chem. 2020;96(October 2019):103576.
Anggraeni VJ, Purwaniati P, Budiana W, Nurdin T. Molecular docking compounds in methanol extract of mango leaves (Mangifera indica L.) as anti-inflammatory agent. J Kim Ris. 2022;7(1):57–65.
Musfiroh I, Azura AR, Rahayu D. prediction of asiatic acid derivatives affinity Against SARS-CoV-2 main protease using molecular docking. Pharm Sci Res. 2020;7(4):57–64.
Ren L, Qin X, Cao X, Wang L, Bai F, Bai G, Shen Y. Structural insight into substrate specificity of human intestinal maltase-glucoamylase. Protein Cell. 2011;2(10):827–36.
Tunnisa F, Nur Faridah D, Afriyanti A, Rosalina D, Ana Syabana M, Darmawan N, Dewi Yuliana N. Antioxidant and antidiabetic compounds identification in several Indonesian underutilized Zingiberaceae spices using SPME-GC/MSbased volatilomics and in silico methods. Food Chem X. 2022;14(March):100285.
Sururi AM, Raihan M, Aisa ER, Safitri FN, Constaty IC, Tukiran. Anti-inflammatory activity of stem bark dichloromethane fraction Syzigium samarangense extract as COX-2 inhibitor: A bioinformatics approach. J Kim Ris. 2022;7(2):94–100.
Iheagwam FN, Israel EN, Kayode KO, De Campos OC, Ogunlana OO, Chinedu SN. GC-MS analysis and inhibitory evaluation of Terminalia catappa leaf extracts on major enzymes linked to diabetes. Evidence-based Complement Altern Med. 2019;2019.
Aati HY, Anwar M, Al-Qahtani J, Al-Taweel A, Khan KUR, Aati S, Usman F, Ghalloo BA, Asif HM, Shirazi JH, Abbasi A. Phytochemical profiling, in vitro biological activities, and in-silico studies of Ficus vasta Forssk.: An unexplored plant. Antibiotics. 2022;11(9):1155.
Wronka M, Krzemińska J, Młynarska E, Rysz J, Franczyk B. The influence of lifestyle and treatment on oxidative stress and inflammation in diabetes. Int J Mol Sci. 2022;23(24): 15743.
Andhiarto Y, Praditapuspa EN. In silico analysis and ADMET prediction of flavonoid compounds from Syzigium cumini var. album on α-glucosidase receptor for searching antidiabetic drug candidates. Pharmacogn J. 2022;14(6):736–43.
Wati W, Widodo GP, Herowati R. Prediction of pharmacokinetics parameter and molecular docking study of antidiabetic compounds from Syzygium polyanthum and Syzygium cumini. J Kim Sains dan Apl. 2020;23(6):189–95.
El-Nashar HAS, Eldehna WM, Al-Rashood ST, Alharbi A, Eskandrani RO, Aly SH. GC/MS analysis of essential oil and enzyme inhibitory activities of Syzygium cumini (Pamposia) grown in docking studies. Molecules. 2021;26(22):6984.
Tijjani H, Olatunde A, Adegunloye AP, Ishola AA. In silico insight into the interaction of 4-aminoquinolines with selected SARS-CoV-2 structural and nonstructural proteins. In: Coronavirus Drug Discovery: Druggable Targets and In Silico Update: Volume 3. Elsevier; 2022. p. 313–33.
Choy Y Bin, Prausnitz MR. The rule of five for non-oral routes of drug delivery: Ophthalmic, inhalation and transdermal. Pharm Res. 2011;28(5):943–8.
Gogoi N, Chowdhury P, Goswami AK, Das A, Chetia D, Gogoi B. Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease. Mol Divers. 2021;25(3):1745–59.
Egieyeh SA, Syce J, Malan SF, Christoffels A. Prioritization of anti-malarial hits from nature: Chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs. Malar J. 2016;15(1):1–23.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Tropical Journal of Natural Product Research (TJNPR)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
